-+ 0.00%
-+ 0.00%
-+ 0.00%

Covista (CVSA) Dropped, So What Is Driving Attention Now?

Simply Wall St·11/02/2026 04:39:46
Listen to the news

Covista stock reaction to earnings, guidance and CFO transition

Covista (CVSA) has been in focus after first quarter results, a higher 2027 revenue outlook, an updated share repurchase tally and news that long serving Chief Financial Officer Robert Phelan plans to retire.

The mix of earnings detail, capital return activity and an upcoming finance leadership change gives you several angles to assess how the business is being run today and what could shape sentiment toward the stock.

Recent news has landed against a choppy tape for Covista, with the share price down 3.44% over the past day and 5.49% over the last week as investors digest the higher 2027 revenue outlook, share repurchases and the planned CFO transition. Even with that short term pullback, the year to date share price return of 19.01% and a 1 year total shareholder return of 30.05% keep the longer term picture constructive. This is supported by very strong 3 and 5 year total shareholder returns of 125.24% and 278.82%, which show how earlier buyers have already been rewarded for staying invested.

Compare Covista’s setup with a curated group of education and training providers that also pair earnings updates with buybacks and robust balance sheets using the list of solid balance sheet and fundamentals (24 results).

After a strong multi year run and a recent pullback, Covista now trades at a higher earnings multiple, yet still appears undervalued on fair value models. Does that mix still tilt the risk reward in favour of new buyers?

Most Popular Narrative: 22% Undervalued

Covista’s most followed valuation story pegs fair value at $159.50 versus the last close of $124.33, which frames the recent pullback as a discount within that model rather than a break in the thesis.

Persistent health care workforce shortages in nursing, medicine and behavioral health create a structural need for large scale training capacity, which can support sustained demand for Covista's programs and underpin revenue growth.

Rising acceptance of flexible digital learning for working adults, reflected in Walden's record 52,400 students and ongoing program launches in areas like applied behavioral analysis and clinical psychology, can expand addressable markets and support earnings through scale efficiencies.

See why 5 investors see Covista as 22% undervalued.

The narrative applies a 7.39% discount rate to future cash flows and earnings, then arrives at the $159.50 fair value by assuming healthcare education demand and digital learning trends support the business over time. At a 22.1% discount to that estimate, the current share price reflects a gap that hinges on how much conviction you place in those sector drivers and Covista’s ability to keep converting them into earnings and cash generation.

Result: Fair Value of $159.50 (UNDERVALUED)

Still, the bullish Covista narrative leans heavily on healthcare shortages and digital learning demand. Both of these could be challenged by policy shifts or cheaper online competitors.

Find out about the key risks to this Covista narrative.

Another view on Covista’s valuation

The popular story paints Covista as 22% undervalued on fair value models, yet its 14.9x P/E is richer than both the US Consumer Services industry at 12.2x and peer average at 12.1x, while sitting below a 20.5x fair ratio. Is that a margin of safety or a valuation trap in the making?

To see how that earnings multiple stacks up in more detail, including how the fair ratio could influence where the market eventually prices Covista, See what the numbers say about this price — find out in our valuation breakdown.

NYSE:CVSA P/E Ratio as at Nov 2026
NYSE:CVSA P/E Ratio as at Nov 2026

Next Steps

That mix of confidence and doubt around Covista only matters if you test it against the raw numbers yourself and decide where you land. To pressure test the upside case that others are watching, spend a few minutes with the 4 key rewards

Looking for more Covista investment ideas?

If you like the Covista story but do not want all your risk in a single stock, consider broadening your watchlist with a few focused stock screens.